Securities / Derivatives

CSRC to Expand Sponsor Obligations on Due Diligence

24/11/2021

New draft guidelines seek to ensure better quality information disclosures for listed companies by expanding the scope of sponsors’ responsibilities.

AFCA Launches Benchmarking Tool for Complaints Resolution

23/11/2021

The platform enables FIs to track complaints resolution and compare their performance against an anonymised set of similar financial firms.

Securities / Derivatives

IOSCO Issues Final Report on Regulating ESG Ratings & Data

23/11/2021

Regulators should promote more transparency regarding the methodologies that ESG ratings and data product providers use, IOSCO says.

Capital / Liquidity

FSB Publishes 2021 List of Global Systemically Important Banks

23/11/2021

JP Morgan, BNP and Goldman have moved to higher buckets, meaning they will have to hold larger capital buffers from 1 January 2023.

Korea FSS Asks Banks to Review Rate Setting Practices

22/11/2021

Banks are also asked to allow borrowers to demand rate adjustments when their wealth increases or credit ratings improve.

Securities / Derivatives

Philippines Set to Issue First Sovereign Green Bonds

22/11/2021

The Department of Finance is finalising a sustainable finance framework for the issuance of the Philippines’ first-ever sovereign green bonds.

Securities / Derivatives

Bursa Malaysia Appoints ICDM to Facilitate Director Accreditations

22/11/2021

First-time directors of listed companies and directors of newly-listed companies must complete an enhanced accreditation programme starting in 2022.

Market Infrastructure

Bank Indonesia Issues Implementation Regulations for BI-FAST

22/11/2021

Banks with IDR 6 trillion in core capital, and non-bank institutions with IDR 100 billion in paid-up capital, can be direct participants of BI-FAST.

Big Picture

More China SOE Bond Defaults Expected in 2022, says Moody’s

22/11/2021

Defaults by Chinese SOEs will increase in 2022, but Chinese authorities will intervene in situations with potential spillover risks.